Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 695)
Posted On: 01/05/2021 6:03:09 PM
Post# of 157807
Posted By: Borel Fields
"Thinning, Leaky Brain Blood Vessels Seen in COVID-19"

- NEJM, as reported in Medpage Today

I'm pretty sure we've been told endothelial cell inflammation is RANTES driven, so not a surprise to leronlimab followers. We know we also cross the BBB - can we fix this?

More from MPT:

"— High-resolution MRI shows injury and inflammation, but no direct viral attack
by Judy George, Senior Staff Writer, MedPage Today January 4, 2021

Microvascular brain injury was seen in COVID-19 patients who died, but no evidence of a direct viral attack on the brain was detected, a pathology report showed.

Damage caused by thinning and leaky brain blood vessels consistently appeared on high-resolution MRI, but there were no signs of SARS-CoV-2 infection in tissue samples, reported Avindra Nath, MD, clinical director of the National Institute of Neurological Disorders and Stroke (NINDS), and co-authors in a New England Journal of Medicine letter."

BTW, appreciate any insight on how we cross BBB. I do understand injury and inflammation can temporarily disrupt it - T-cells sometimes get in. Are we there riding on CCR5 receptors on T-cells?















(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site